Search clinical trials for: KRAS wild type
Total 65301 results
-
Sun Yat-sen UniversityRecruiting
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
GCS IHFB Cognacq-JayRecruiting
-
Taiho Oncology, Inc.Institut de Recherches Internationales ServierCompletedRefractory Metastatic Colorectal CancerUnited States, Poland, France, Germany, Hungary, Italy, Russian Federation, Ukraine, Austria, Belgium, Brazil, Denmark, Puerto Rico, Spain
-
UNC Lineberger Comprehensive Cancer CenterBristol-Myers Squibb; AmgenActive, not recruitingColon CancerUnited States
-
Bahria UniversityCompletedIrritable Bowel Syndrome With DiarrheaPakistan
-
AmgenCompletedMetastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon CancerUnited States, Belgium, Canada, Italy, Germany, Spain
-
Translational Genomics Research InstituteEli Lilly and CompanyWithdrawnMetastatic Colorectal CancerUnited States
-
AmgenCompletedMetastatic Colorectal CancerSweden, Belgium, Czechia, Italy, Poland, United States, France, Korea, Republic of, Peru, Philippines, Russian Federation, United Kingdom, China, Canada, Israel, Lithuania, Australia, South Africa, Bulgaria, Romania, Taiwan, Latvia, Serbi... and more
-
Armando Santoro, MDCompletedColorectal Cancer Metastatic | C-met OverexpressionItaly
-
AmgenCompletedPsoriatic ArthritisUnited Kingdom, Belgium, United States, Canada, Australia, Taiwan, Czechia, Russian Federation, Hungary, Poland, Korea, Republic of, Italy, New Zealand, France, Bulgaria, Estonia, Romania, Lithuania
-
University Health Network, TorontoCompletedColorectal Cancer | KRAS Wildtype | NRAS Wildtype | BRAF WildtypeCanada
-
NSABP Foundation IncPuma Biotechnology, Inc.Active, not recruitingMetastatic Colorectal CancerUnited States
-
NSABP Foundation IncWithdrawnColorectal CancerUnited States
-
NSABP Foundation IncBristol-Myers SquibbCompletedMetastatic Colorectal CancerUnited States
-
Daiichi Sankyo, Inc.CompletedMetastatic Colorectal CancerUnited States, Russian Federation, Germany, France, Italy
-
John Strickler, M.D.ExelixisCompletedColorectal CancerUnited States
-
Asan Medical CenterCompletedAdvanced Colorectal CancerKorea, Republic of
-
Henan Cancer HospitalCompletedWild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer
-
Novartis PharmaceuticalsCompletedType II Diabetes Mellitus | Congestive Heart FailureRussian Federation, Singapore, Italy, Czechia, Lithuania, Germany, Guatemala, India, Denmark, Estonia, Slovakia, Romania, Latvia, Greece, Poland
-
NYU Langone HealthBristol-Myers Squibb; Eli Lilly and CompanyCompletedNeoplasm Metastasis | Colorectal CancerUnited States
-
Georgetown UniversityMillennium Pharmaceuticals, Inc.TerminatedColorectal CancerUnited States
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownSquamous Cell Lung Cancer | Triple-Negative Breast Cancer | Non-squamous Cell Lung Cancer With KRAS Mutations | Non-squamous Cell Lung Cancer With Wild-type KRASUnited Kingdom
-
M.D. Anderson Cancer CenterAmgenCompletedGastrointestinal CancerUnited States
-
Vejle HospitalCompletedCholangiocarcinomaDenmark
-
Dr. Reddy's Laboratories LimitedAmgenUnknown
-
Hospices Civils de LyonCompletedRectal AdenocarcinomaFrance
-
Shanghai Zhangjiang Biotechnology Limited CompanyShanghai Biomabs Pharmaceutical Co., Ltd.CompletedMetastatic Colorectal Cancer
-
Georgetown UniversityNovartisTerminatedHead and Neck Cancer | Colorectal CancerUnited States
-
PfizerTerminatedMetastatic Colorectal CancerKorea, Republic of, United States, Japan, Spain
-
Austrian Breast & Colorectal Cancer Study GroupMerck Gesellschaft mbH, AustriaTerminatedColorectal Cancer | SteatohepatitisAustria
-
Gruppo Oncologico del Nord-OvestUnknown
-
EPS CorporationCompletedLiver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal CancerJapan
-
EPS CorporationCompleted
-
HiberCell, Inc.TerminatedColorectal CancerUnited States, Puerto Rico, Germany, France
-
Merck KGaA, Darmstadt, GermanyMerck Ltd., IndiaTerminated
-
National Cancer Institute (NCI)University of Chicago; City of Hope Medical Center; University of Southern California and other collaboratorsCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; AmgenCompletedColorectal CancerUnited States
-
TakedaCompleted
-
AmgenCompletedMetastatic Colorectal CancerRomania, Canada, Korea, Republic of, Philippines, Lithuania, Serbia, Latvia, Estonia, Greece, India, China, Croatia, Mexico, Malaysia, Chile, Brazil
-
Swiss Group for Clinical Cancer ResearchTerminated
-
Genentech, Inc.CompletedColorectal CancerAustralia, Belgium, Spain, United States, New Zealand, United Kingdom, Italy, Romania, France, Germany
-
Hans-Joachim Schmoll, MDBiocompatibles UK LtdTerminated
-
European Organisation for Research and Treatment...Roche Pharma AG; AmgenTerminatedColorectal Cancer Metastatic | Liver Metastases | KRAS Wild Type Colorectal CancerFrance, Belgium, Austria, Netherlands, Spain, Switzerland
-
University of UtahTerminatedKRAS and NRAS Wild-type Colorectal CancerUnited States
-
Merrimack PharmaceuticalsSanofiCompletedColorectal Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Squamous Cell Head and Neck Cancer | Other Tumors With EGFR DependenceUnited States
-
University of RochesterAmgenCompletedBiliary Tract Cancer | Gallbladder CancerUnited States
-
European Organisation for Research and Treatment...Merck KGaA, Darmstadt, GermanyTerminated
-
AmgenCompletedMetastatic Colorectal Cancer